Inspection Findings:
Based on observation, interview, and record review, it was determined the facility failed to ensure written, signed physician orders were documented in the resident's facility record for all medications and treatments the facility was responsible to administer, and that medication orders were carried out as prescribed for 5 of 5 sampled residents whose orders were reviewed (#s 1, 2, 3, 4, and 5) Findings include, but are not limited to:1. Resident 2 was admitted to the facility in 09/2023 with diagnoses including heart failure and lower extremity fracture. Resident 2's 10/2023 MAR indicated they administered their own medications. Review of Resident 2's record showed the "medication self-administration safety screen" dated 09/13/23 was incomplete, with no information or safety determination documented. No evaluation of Resident 2's ability to administer their own medications was completed.A progress note dated 10/17/23 stated "Received orders Resident 2 may not self-administer their own medications"In an interview on 10/19/23, Staff 18 (Med Aide) confirmed Resident 2 continued to administer his/her own medications and an observation of the med cart showed no medications stored for Resident 2. The facility had a physician order that Resident 2 was not to self-administer medications, however, interview and record reviewed confirmed Resident 2 continued to keep medications in their room and self-administer.The need to ensure physician's orders were followed was discussed with Staff 1 (Administrator), Staff 15 (ED), Staff 2 (Wellness Director), Staff 12 (LPN) and Staff 14 (RN Consultant) on 10/20/23. They acknowledged the findings. 2. Resident 3 was admitted to the facility in 05/2023, with diagnoses including heart disease and chronic pain.Review of Resident 3's 10/2023 MAR and physician's orders showed the following medications were administered without a signed order:* Duloxetine DR 30 mg cap (anti-depressant);* Fluconazole 200 mg tab (anti-fungal);* Spironolcactone 25 mg tab (diuretic);* Potassium CHL ER 200 MEQ (supplement);* Trelegy Ellipta 100-62.5 MCG (steroid inhaler);* Acetaminophen 500 MG 2 tablets (analgesic); and* Albuterol 90 MCG (asthma inhaler).In an interview on 10/19/23, Staff 1 acknowledged there were not physician's orders for the medications the facility was administering.The need to ensure written, signed physician orders were documented in the resident's facility record for all medications and treatments the facility was responsible to administer was discussed with Staff 1, Staff 15 (ED), Staff 2 (Wellness Director), Staff 12 (LPN) and Staff 14 (RN Consultant) on 10/20/23. They acknowledged the findings, and no additional documentation was provided.On 10/20/23 prior to survey's exit, the facility received signed physician orders from the pharmacy.3. Resident 5 was admitted to the facility in 10/2022 with diagnoses including Type II Diabetes and hypothyroidism.Review of Resident 5's 10/2023 MAR and current physician's orders showed the following medications were administered without a signed order:* Amlipodine 2.5 mg (blood pressure medication);* Furosemide 40 mg (diuretic);* Insulin Aspart 100 u/ml injection (anti-diabetic);* Jardiance 25 mg (anti-diabetic);* Levothyroxine 112 mcg (thyroid hormone);* Losartan 50 mg (blood pressure);* Trulicity 4.5 mg (anti-diabetic);* Pantoprazole 40 mg (antacid);* Venlafaxine 75 mg (antidepressant);* Eliquis 5mg (blood thinner);* Budesonide 160-4.5mcg (anti-asthma);* Lantus Solostar pen injection (anti-diabetic);* Gabapentin 100 MG (analgesic);* Methocarbamol 750 mg (analgesic); and* Acetaminophen 500 mg (analgesic).In an interview on 10/19/23, Staff 1 acknowledged there were not physician's orders for the medications the facility was administering.The need to ensure written, signed physician orders were documented in the resident's facility record for all medications and treatments the facility was responsible to administer was discussed with Staff 1, Staff 15 (ED), Staff 2 (Wellness Director), Staff 12 (LPN) and Staff 14 (RN Consultant) on 10/20/23. They acknowledged the findings, and no additional documentation was provided.On 10/20/23 prior to survey's exit, the facility received signed physician orders from the pharmacy.
3. Resident 1's MAR, dated 10/01/23 through 10/17/23, and signed physician orders, dated 10/12/23, were reviewed. The following deficiencies were identified:There were no written, signed orders for the following medications in Resident 1's record:* Aspirin (anticoagulant);* Clobetasol ointment (for irritation);* Clopidogrel (anticoagulant);* Multivitamin tab (supplement);* Nizoral A-D shampoo (for itching);* Pantoprazole (Gastroesophageal Reflux Disease); * Potassium Chloride (venous hypertension);* Amlodipine (hypertension);* Buspirone (for anxiety);* Enalapril Maleate (hypertension);* Gabapentin (for neuropathy);* PRN acetaminophen (for fever or mild pain);* PRN barrier cream (for prevention and healing of skin breakdown);* PRN Bisacodyl supp (constipation);* PRN Bisacodyl tablet (for no BM, by 4th day);* PRN calcium carb (Gastroesophageal Reflux Disease);* PRN clobetasol prop (itchy scaly scalp);* PRN Corn Remover 40% Pads (corn remover);* PRN Ibuprofen (for mild to moderate pain or inflammation);* PRN Ketoconazole 2% shampoo (for dry scalp);* PRN Milk of Magnesia (for no BM, by 3rd day);* PRN PEG 3350 Powder (constipation); and* PRN Preparation H 1% Cream (hemorrhoids).On 10/19/23, Staff 1 (Administrator) acquired signed physician's orders for Resident 1's medications before the survey was completed.On 10/20/23, the need to ensure the facility had written, signed orders in every resident's record for all medications and treatments being administered was discussed with Staff 1, Staff 15 (ED), Staff 2 (Wellness Director), Staff 12 (LPN) and Staff 14 (RN Consultant). They acknowledged the findings.
4. Resident 4 was admitted to the facility in 08/2023 with diagnoses including chronic pain syndrome.The resident's MAR dated 10/01/23 through 10/16/23 and current physician's orders were reviewed. a. There was no documented evidence of signed physician orders in the resident's facility record for the following medications:* Alprazolam 0.5 mg - Take one tablet orally in the evening for anti-anxiety;* Bactrim DS 800-160 mg - Take one tablet by mouth two times a day for 12 days for cellulitis; and* Spironolactone 50 mg - take one table by mouth daily as a diuretic, hold until patient completes course of Bactrim.On 10/20/23 prior to survey's exit, the facility received signed physician orders from the pharmacy.b. Resident 4 had physician orders for oxycodone 15 mg to be administered every eight hours as needed for severe pain. On 10/11/23, the resident received this medication at 12:02 am, 3:04 am, 7:29 am and 2:44 pm. The medication was given earlier than the prescribed eight hour parameter for all administrations. On 10/19/23 at 2:07 pm, Staff 13 (Regional Representative) confirmed the medication was erroneously set-up in the electronic MAR to allow administration prior to the prescribed parameter. Staff 13 corrected the electronic MAR at that time.The need to ensure physician orders were in the residents' facility record and medication orders were carried out as prescribed was discussed with Staff 1 (Administrator), Staff 15 (ED), Staff 2 (Wellness Director), Staff 12 (LPN) and Staff 14 (RN Consultant) on 10/20/23. They acknowledged the findings.
Plan of Correction:
1. Resident #2's self-administation safety screen has been updated. Will work with resident, her physician, and caseworker on an agreeable medication administration plan.2. Resident #1, #3 and #5's signed orders were obtained and are in the resident charts.3. Resident #4's PRN order was updated to reflect the accurate order time frame. 4. Signed orders will be reviewed by the administrator or designee and obtained for all other residents.5. PRN orders will be reviewed by the administrator or designee and corrected as needed for all other residents.6. Staff have been educated PRN time frames and administration. 7. Audits will be conducted of signed orders by the administrator or designee quarterly and findings reported to the Quality Assurance Committee. PRN orders will be audited by the administrator or designee monthly and findings reported to the executive director.